Trade off analysis of risk, benefit, and adherence claims in DTC ad HCP promotion
Ended Awarded Last action
- Contract number
- 75F40120F80378
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $757,023
Award facts
- Opportunity
-
- Professional Service Schedule Solicitation · Posted Jun 10, 2019
- Contract value 100% obligated
- $757,023.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $757,024 |
About this award
The Food and Drug Administration awarded an $757K firm fixed-price delivery order to Research Triangle Institute (RTI International) on August 3, 2020, for a trade-off analysis of risk, benefit, and adherence claims in direct-to-consumer advertising and healthcare provider promotion. The contract, which ultimately completed on August 16, 2024, was performed at RTI's headquarters in Research Triangle Park, North Carolina. This work supports FDA's Center for Drug Evaluation and Research mission to ensure that drug advertising claims are appropriately balanced and evidence-based. The delivery order was issued without a set-aside designation, reflecting RTI's competitive standing as a nonprofit research organization with extensive experience supporting FDA initiatives across tobacco, opioid, and pharmaceutical domains.
RTI engaged two subcontractors to support the project: Survey Sampling International, LLC, which was awarded a subcontract on February 14, 2023, to provide survey sampling and statistical analysis capabilities, and L&E Research, Inc., subcontracted on July 22, 2021, to contribute qualitative research and focus group facilities for stakeholder input. The contract operates under RTI's General Services Administration Multiple Award Schedule arrangement, positioning the organization to deliver specialized research and technical assistance efficiently across the federal government.
Quick answers
Who was awarded contract 75F40120F80378?
75F40120F80378 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on August 3, 2020.
How much is contract 75F40120F80378 worth?
The government has obligated $757,023 on 75F40120F80378.
Is contract 75F40120F80378 an order under another contract?
Yes. 75F40120F80378 is a delivery order under GS00F354CA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40120F80378 competed?
The extent of competition for 75F40120F80378 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award